All Stories

  1. Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis

    Article • Circulation, February 2026, Wolters Kluwer Health

    Mikko I. Mäyränpää

  2. Myocardial sympathetic distal axon loss in subjects with Lewy pathology: an artificial intelligence‐based histopathological analysis

    Article • Alzheimer s & Dementia, December 2025, Wiley

    Dr Per Borghammer, Mikko I. Mäyränpää

  3. Variability in arteriolosclerosis in different brain regions: An AI‐based population study of the Oldest‐Old (Vantaa85+)

    Article • Alzheimer s & Dementia, December 2025, Wiley

    Mikko I. Mäyränpää

  4. Microscopic cardiac pathology in forensic autopsies: a comparative study of anabolic androgenic steroid users and non-users

    Article • International Journal of Legal Medicine, October 2025, Springer Science + Business Media

    Mikko I. Mäyränpää

  5. Intranodal expansion of follicular T helper cells in patients with multiple sclerosis

    Article • JCI Insight, October 2025, American Society for Clinical Investigation

    Mikko I. Mäyränpää

  6. Myocardial sympathetic distal axon loss in subjects with Lewy pathology in three autopsy cohorts

    Article • Acta Neuropathologica, August 2025, Springer Science + Business Media

    Dr Per Borghammer, Mikko I. Mäyränpää

  7. Predicting Anabolic Androgenic Steroid Doping among Specialized Health Care Patients with Elastic Net Regression Reveals Potential Laboratory Variables for “Patient Biological Passport”

    Article • Sports Medicine - Open, May 2025, Springer Science + Business Media

    Mikko I. Mäyränpää

  8. Parvovirus B19 and Human Herpes Virus 6B and 7 Are Frequently Found DNA Viruses in the Human Thymus But Show No Definitive Link With Myasthenia Gravis

    Article • The Journal of Infectious Diseases, December 2024, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  9. Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis

    Article • European Journal of Heart Failure, December 2024, Wiley

    Mikko I. Mäyränpää

  10. LATE‐NC IN THE VERY ELDERLY– THE POPULATION‐BASED VANTAA 85+ ‐STUD

    Article • Alzheimer s & Dementia, December 2024, Wiley

    Mikko I. Mäyränpää

  11. Reduction in mucosal‐associated invariant T cells (MAIT) in APECED patients is associated with elevated serum IFN‐γ concentration

    Article • European Journal of Immunology, September 2024, Wiley

    Mikko I. Mäyränpää

  12. Lung Cancer in Finland

    Article • Journal of Thoracic Oncology, September 2024, Elsevier

    Heidi Andersen, Mikko I. Mäyränpää

  13. Infective SARS-CoV-2 in Skull Sawdust at Autopsy, Finland

    Article • Emerging Infectious Diseases, August 2024, Centers for Disease Control and Prevention (CDC)

    Mikko I. Mäyränpää

  14. Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study

    Article • Brain, June 2024, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  15. Increased type 1 inflammation in gynecologic cervicovaginal samples in patients with APS-1

    Article • Journal of Allergy and Clinical Immunology, June 2024, Elsevier

    Mikko I. Mäyränpää, Saila Laakso

  16. Dysregulated germinal center reaction with expanded T follicular helper cells in autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy lymph nodes

    Article • Journal of Allergy and Clinical Immunology, May 2024, Elsevier

    Mikko I. Mäyränpää, Saila Laakso

  17. Prediction model for anabolic androgenic steroid positivity in forensic autopsy cases – a new tool to the autopsy room

    Article • International Journal of Legal Medicine, April 2024, Springer Science + Business Media

    Mikko I. Mäyränpää

  18. Association of anabolic androgenic steroid use with perimortem polypharmacy, antemortem prescription drug use, and utilization of health care services – A Finnish triple register study of forensic autopsy cases

    Article • Forensic Science International, March 2024, Elsevier

    Mikko I. Mäyränpää

  19. Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients

    Article • Virus Research, March 2024, Elsevier

    Mikko I. Mäyränpää

  20. A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer

    Article • Journal of Translational Medicine, February 2024, Springer Science + Business Media

    Mikko I. Mäyränpää

  21. Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis

    Article • Journal of Nuclear Cardiology, December 2023, Elsevier

    Mikko I. Mäyränpää

  22. Cardiac Death

    Article • November 2023, Taylor & Francis

    Professor Antti Sajantila, Mikko I. Mäyränpää

  23. Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

    Article • Nature Communications, November 2023, Springer Science + Business Media

    Dr Lukasz Kuryk, DSc, MBA, Mikko I. Mäyränpää

  24. Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer

    Article • OncoImmunology, August 2023, Taylor & Francis

    Mikko I. Mäyränpää

  25. Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland

    Article • BMC Women s Health, May 2023, Springer Science + Business Media

    Mikko I. Mäyränpää

  26. Data from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  27. Data from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  28. Supplementary Data from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  29. Supplementary Data from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  30. Supplementary Table S1 from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  31. Supplementary Table S1 from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  32. Supplementary Table S2 from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  33. Supplementary Table S2 from Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify <i>Kras</i>-Mutant Lung Cancers

    Article • April 2023, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  34. Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing

    Article • Lung Cancer, April 2023, Elsevier

    Mikko I. Mäyränpää

  35. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

    Article • European Heart Journal, March 2023, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  36. Pubertal development and hypogonadism in males with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy: a retrospective study

    Article • European Journal of Endocrinology, March 2023, Oxford University Press (OUP)

    Mikko I. Mäyränpää, Saila Laakso

  37. Cardiac magnetic resonance in histologically proven eosinophilic myocarditis

    Article • Journal of Cardiovascular Magnetic Resonance, February 2023, Elsevier

    Mikko I. Mäyränpää

  38. Deep Learning Neural Network-Guided Detection of Asbestos Bodies in Bronchoalveolar Lavage Samples

    Article • Acta Cytologica, January 2023, Karger Publishers

    Mikko I. Mäyränpää

  39. High relative amount of nodular calcification in femoral plaques is associated with milder lower extremity arterial disease

    Article • BMC Cardiovascular Disorders, December 2022, Springer Science + Business Media

    Mikko I. Mäyränpää

  40. Neutrophil proteinase 3 — An LDL- and HDL-proteolyzing enzyme with a potential to contribute to cholesterol accumulation in human atherosclerotic lesions

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, December 2022, Elsevier

    Mikko I. Mäyränpää

  41. Protocol to utilize fresh uncultured human lung tumor cells for personalized functional diagnostics

    Article • STAR Protocols, December 2022, Elsevier

    Mikko I. Mäyränpää

  42. Tankyrase Inhibition Attenuates Cardiac Dilatation and Dysfunction in Ischemic Heart Failure

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Päivi Lakkisto, Mikko I. Mäyränpää

  43. Epicardial transplantation of autologous atrial appendage micrografts: evaluation of safety and feasibility in pigs after coronary artery occlusion

    Article • Scandinavian Cardiovascular Journal, August 2022, Taylor & Francis

    Mikko I. Mäyränpää

  44. Cardiac sarcoidosis and giant cell myocarditis after COVID‐19 infection

    Article • ESC Heart Failure, August 2022, Wiley

    Mikko I. Mäyränpää

  45. Glutamine synthetase in human carotid plaque macrophages associates with features of plaque vulnerability: An immunohistological study

    Article • Atherosclerosis, July 2022, Elsevier

    Mikko I. Mäyränpää

  46. Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma

    Article • Frontiers in Oncology, June 2022, Frontiers

    Mikko I. Mäyränpää

  47. Alterations of Cardiac Protein Kinases in Cyclic Nucleotide-Dependent Signaling Pathways in Human Ischemic Heart Failure

    Article • Frontiers in Cardiovascular Medicine, June 2022, Frontiers

    Päivi Lakkisto, Mikko I. Mäyränpää

  48. APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study

    Article • Acta Neuropathologica Communications, December 2021, Springer Science + Business Media

    Mikko I. Mäyränpää

  49. Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells

    Article • Science Immunology, November 2021, American Association for the Advancement of Science

    Mikko I. Mäyränpää

  50. GRINL1A Complex Transcription Unit Containing GCOM1, MYZAP, and POLR2M Genes Associates with Fully Penetrant Recessive Dilated Cardiomyopathy

    Article • Frontiers in Genetics, November 2021, Frontiers

    Mikko I. Mäyränpää

  51. Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion

    Article • JACC Case Reports, November 2021, Elsevier

    Mikko I. Mäyränpää

  52. Epicardial transplantation of autologous atrial appendage micrografts–evaluation of safety and feasibility in pigs after coronary artery occlusion

    Article • October 2021, Cold Spring Harbor Laboratory Press

    Mikko I. Mäyränpää

  53. Severe Spontaneous Atherosclerosis in two Korat Breed Cats is Comparable to Human Atherosclerosis

    Article • Journal of Comparative Pathology, October 2021, Elsevier

    Mikko I. Mäyränpää

  54. Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments

    Article • Cell Reports Medicine, August 2021, Elsevier

    Mikko I. Mäyränpää

  55. Warfarin Treatment Is Associated to Increased Internal Carotid Artery Calcification

    Article • Frontiers in Neurology, July 2021, Frontiers

    Mikko I. Mäyränpää

  56. SOX9 has distinct roles in the formation and progression of different non‐small cell lung cancer histotypes

    Article • The Journal of Pathology, June 2021, Wiley

    Mikko I. Mäyränpää

  57. Lysophosphatidylcholine in phospholipase A2-modified LDL triggers secretion of angiopoietin 2

    Article • Atherosclerosis, June 2021, Elsevier

    Mikko I. Mäyränpää

  58. High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma

    Article • The Journal of Pathology Clinical Research, May 2021, Wiley

    Mikko I. Mäyränpää

  59. Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts

    Article • Journal of the American Heart Association, March 2021, Wolters Kluwer Health

    Mikko I. Mäyränpää

  60. Cardiovascular disease risk factors induce mesenchymal features and senescence in mouse cardiac endothelial cells

    Article • eLife, March 2021, eLife

    Mikko I. Mäyränpää

  61. Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis

    Article • Human Pathology, January 2021, Elsevier

    Mikko I. Mäyränpää

  62. Osteoid Metaplasia in Femoral Artery Plaques Is Associated With the Clinical Severity of Lower Extremity Artery Disease in Men

    Article • Frontiers in Cardiovascular Medicine, December 2020, Frontiers

    Mikko I. Mäyränpää

  63. Predictive Factors for Pre-operative Recurrence of Cerebrovascular Symptoms in Symptomatic Carotid Stenosis

    Article • European Journal of Vascular and Endovascular Surgery, December 2020, Elsevier

    Mikko I. Mäyränpää

  64. Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses

    Article • Clinical Lung Cancer, November 2020, Elsevier

    Mikko I. Mäyränpää

  65. Neuropathologic features of four autopsied COVID‐19 patients

    Article • Brain Pathology, August 2020, Wiley

    Professor Antti Sajantila, Mikko I. Mäyränpää

  66. Idiopathic giant cell myocarditis or cardiac sarcoidosis? A retrospective audit of a nationwide case series

    Article • ESC Heart Failure, April 2020, Wiley

    Mikko I. Mäyränpää

  67. Folate Receptor β–Targeted PET Imaging of Macrophages in Autoimmune Myocarditis

    Article • Journal of Nuclear Medicine, April 2020, Society of Nuclear Medicine

    Mikko I. Mäyränpää

  68. Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival

    Article • Human Pathology, April 2020, Elsevier

    Mikko I. Mäyränpää

  69. Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras-Mutant Lung Cancers

    Article • Molecular Cancer Therapeutics, July 2019, American Association for Cancer Research (AACR)

    Mikko I. Mäyränpää

  70. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries

    Article • European Heart Journal, June 2019, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  71. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block

    Article • Circulation Arrhythmia and Electrophysiology, August 2018, Wolters Kluwer Health

    Mikko I. Mäyränpää

  72. Morphology and histology of silent and symptom-causing atherosclerotic carotid plaques – Rationale and design of the Helsinki Carotid Endarterectomy Study 2 (the HeCES2)

    Article • Annals of Medicine, July 2018, Taylor & Francis

    Perttu Lindsberg, Sonja Kasari, Mikko I. Mäyränpää

  73. Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras -driven lung tumours

    Article • The Journal of Pathology, April 2018, Wiley

    Mikko I. Mäyränpää

  74. Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding

    Article • Atherosclerosis, April 2018, Elsevier

    Dr Katariina Öörni, Mikko I. Mäyränpää

  75. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma

    Article • The Journal of Pathology, May 2017, Wiley

    Mikko I. Mäyränpää

  76. Cell of Origin Links Histotype Spectrum to Immune Microenvironment Diversity in Non-small-Cell Lung Cancer Driven by Mutant Kras and Loss of Lkb1

    Article • Cell Reports, January 2017, Elsevier

    Mikko I. Mäyränpää

  77. p38δ MAPKHighlights

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2016, Wolters Kluwer Health

    Dr Katariina Öörni, Mikko I. Mäyränpää

  78. Imatinib treatment attenuates growth and inflammation of angiotensin II induced abdominal aortic aneurysm

    Article • Atherosclerosis, June 2016, Elsevier

    Mikko I. Mäyränpää

  79. Novel 6p21.3 Risk Haplotype Predisposes to Acute Coronary Syndrome

    Article • Circulation Cardiovascular Genetics, February 2016, Wolters Kluwer Health

    Mikko I. Mäyränpää

  80. TRIF adaptor signaling is important in abdominal aortic aneurysm formation

    Article • Atherosclerosis, August 2015, Elsevier

    Mikko I. Mäyränpää

  81. Lipoprotein-associated lipids accumulate in distinctive domains in atherosclerotic arteries.

    Article • American Journal Of Pathology, May 2015, Elsevier

    Dr Katariina Öörni, Dr Satu Lehti, Mikko I. Mäyränpää

  82. Low-Expression Variant of Fatty Acid–Binding Protein 4 Favors Reduced Manifestations of Atherosclerotic Disease and Increased Plaque Stability

    Article • Circulation Cardiovascular Genetics, October 2014, Wolters Kluwer Health

    Mikko I. Mäyränpää

  83. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart

    Article • EMBO Molecular Medicine, January 2014, EMBO

    Mikko I. Mäyränpää, Riikka Kivelä

  84. Osbpl8 Deficiency in Mouse Causes an Elevation of High-Density Lipoproteins and Gender-Specific Alterations of Lipid Metabolism

    Article • PLOS One, March 2013, PLOS

    Mikko I. Mäyränpää

  85. Imatinib mesylate alleviates diarrhea in a mouse model of intestinal allergy

    Article • Neurogastroenterology & Motility, June 2012, Wiley

    Mikko I. Mäyränpää

  86. Serine protease inhibitor A3 in atherosclerosis and aneurysm disease

    Article • International Journal of Molecular Medicine, May 2012, Spandidos Publications

    Mikko I. Mäyränpää

  87. Mast Cells

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2011, Wolters Kluwer Health

    Mikko I. Mäyränpää

  88. Increased expression of leukotriene C4synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm

    Article • Proceedings of the National Academy of Sciences, November 2010, Proceedings of the National Academy of Sciences

    Mikko I. Mäyränpää

  89. OSBP-related protein 11 (ORP11) dimerizes with ORP9 and localizes at the Golgi–late endosome interface

    Article • Experimental Cell Research, November 2010, Elsevier

    Mikko I. Mäyränpää

  90. Vascular Endothelial Growth Factor–Secreting Mast Cells and Myofibroblasts

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2010, Wolters Kluwer Health

    Mikko I. Mäyränpää

  91. Dilated cardiomyopathy alters the expression patterns of CAR and other adenoviral receptors in human heart

    Article • Histochemistry and Cell Biology, December 2009, Springer Science + Business Media

    Mikko I. Mäyränpää

  92. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms

    Article • Journal of Vascular Surgery, August 2009, Elsevier

    Mikko I. Mäyränpää

  93. Rab8 Regulates ABCA1 Cell Surface Expression and Facilitates Cholesterol Efflux in Primary Human Macrophages

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2009, Wolters Kluwer Health

    Mikko I. Mäyränpää

  94. ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model

    Article • BMC Cardiovascular Disorders, March 2009, Springer Science + Business Media

    Mikko I. Mäyränpää

  95. Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves

    Article • Journal of Lipid Research, July 2008, Elsevier

    Mikko I. Mäyränpää

  96. The R-Ras interaction partner ORP3 regulates cell adhesion

    Article • Journal of Cell Science, February 2008, The Company of Biologists

    Sanna Lehtonen, Mikko I. Mäyränpää

  97. OSBP-related Protein 8 (ORP8) Suppresses ABCA1 Expression and Cholesterol Efflux from Macrophages

    Article • Journal of Biological Chemistry, January 2008, Elsevier

    Mikko I. Mäyränpää

  98. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques

    Article • Atherosclerosis, November 2007, Elsevier

    Mikko I. Mäyränpää

  99. Bone densitometry in the diagnosis of vertebral fractures in children: Accuracy of vertebral fracture assessment

    Article • Bone, September 2007, Elsevier

    Mikko I. Mäyränpää

  100. Mast cells in vulnerable atherosclerotic plaques – a view to a kill

    Article • Journal of Cellular and Molecular Medicine, July 2007, Wiley

    Mikko I. Mäyränpää

  101. Complement regulation in human atherosclerotic coronary lesions

    Article • Atherosclerosis, May 2007, Elsevier

    Mikko I. Mäyränpää

  102. Improved Identification of Endothelial Erosion by Simultaneous Detection of Endothelial Cells (CD31/CD34) and Platelets (CD42b)

    Article • Endothelium, January 2007, Taylor & Francis

    Mikko I. Mäyränpää

  103. Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion

    Article • Coronary Artery Disease, November 2006, Wolters Kluwer Health

    Mikko I. Mäyränpää

  104. Endothelial Apoptosis Does Not Determine Symptom Status in Carotid Artery Disease

    Article • Cerebrovascular Diseases, September 2006, Karger Publishers

    Mikko I. Mäyränpää

  105. Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves

    Article • Arteriosclerosis Thrombosis and Vascular Biology, August 2006, Wolters Kluwer Health

    Dr Katariina Öörni, Mikko I. Mäyränpää

  106. Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology

    Article • Histochemistry and Cell Biology, March 2006, Springer Science + Business Media

    Annele Sainio, Mikko I. Mäyränpää

  107. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves

    Article • European Heart Journal, January 2006, European Society of Cardiology

    Mikko I. Mäyränpää

  108. Increased expression of bradykinin type-1 receptors in endothelium of intramyocardial coronary vessels in human failing hearts

    Article • AJP Heart and Circulatory Physiology, May 2005, American Physiological Society

    Mikko I. Mäyränpää

  109. Induction of local angiotensin II-producing systems in stenotic aortic valves

    Article • Journal of the American College of Cardiology, November 2004, Elsevier

    Mikko I. Mäyränpää

  110. Cysteine Protease Cathepsin F Is Expressed in Human Atherosclerotic Lesions, Is Secreted by Cultured Macrophages, and Modifies Low Density Lipoprotein Particlesin Vitro

    Article • Journal of Biological Chemistry, June 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Katariina Öörni, Mikko I. Mäyränpää

  111. Arterial endothelial denudation by intraluminal use of papaverine–NaCl solution in coronary bypass surgery

    Article • European Journal of Cardio-Thoracic Surgery, April 2004, Oxford University Press (OUP)

    Mikko I. Mäyränpää

  112. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure

    Article • Biochemical and Biophysical Research Communications, August 2003, Elsevier

    Mikko I. Mäyränpää

  113. Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure

    Article • Journal of the American College of Cardiology, July 2002, Elsevier

    Mikko I. Mäyränpää